• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神奇蛋白(Magicin)是一种新型细胞骨架蛋白,与神经纤维瘤病2型肿瘤抑制因子默林(merlin)和生长因子受体结合蛋白2(Grb2)相关联。

Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.

作者信息

Wiederhold Thorsten, Lee Ming-Fen, James Marianne, Neujahr Ralph, Smith Nicole, Murthy Anita, Hartwig John, Gusella James F, Ramesh Vijaya

机构信息

Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.

出版信息

Oncogene. 2004 Nov 18;23(54):8815-25. doi: 10.1038/sj.onc.1208110.

DOI:10.1038/sj.onc.1208110
PMID:15467741
Abstract

Neurofibromatosis 2 (NF2) is a dominantly inherited disorder characterized by bilateral vestibular schwannomas and meningiomas. Merlin, the neurofibromatosis 2 tumor suppressor protein, is related to the ERM (ezrin, radixin, moesin) proteins and, like its family members, is thought to play a role in plasma membrane-cytoskeletal interactions. We report a novel protein as a merlin-specific binding partner that we have named magicin (merlin and Grb2 interacting cytoskeletal protein) and show that the two proteins interact in vitro and in vivo as well as colocalize beneath the plasma membrane. Magicin is a 24 kDa protein that is expressed in many cell lines and tissues. Magicin, similar to merlin, associates with the actin cytoskeleton as determined by cofractionation, immunofluorescence and electron microscopy. Analysis of the magicin sequence reveals binding motifs for the adaptor protein Grb2. Employing affinity binding, blot overlay and co-immunoprecipitation assays, we demonstrate an interaction between Grb2 and magicin. In addition, merlin is capable of forming a ternary complex with magicin and Grb2. These results support a role for merlin in receptor-mediated signaling at the cell surface, and may have implications in the regulation of cytoskeletal reorganization.

摘要

神经纤维瘤病2型(NF2)是一种常染色体显性遗传病,其特征为双侧前庭神经鞘瘤和脑膜瘤。默林蛋白是神经纤维瘤病2型的肿瘤抑制蛋白,与ERM(埃兹蛋白、根蛋白、膜突蛋白)相关,并且与其家族成员一样,被认为在质膜-细胞骨架相互作用中发挥作用。我们报道了一种新的蛋白,它是默林蛋白特异性结合伴侣,我们将其命名为魔奇蛋白(默林蛋白和Grb2相互作用细胞骨架蛋白),并证明这两种蛋白在体外和体内均能相互作用,且在质膜下共定位。魔奇蛋白是一种24 kDa的蛋白,在许多细胞系和组织中均有表达。通过共分级分离、免疫荧光和电子显微镜检测发现,魔奇蛋白与肌动蛋白细胞骨架相关,与默林蛋白相似。对魔奇蛋白序列的分析揭示了其与衔接蛋白Grb2的结合基序。利用亲和结合、印迹覆盖和免疫共沉淀分析,我们证实了Grb2与魔奇蛋白之间存在相互作用。此外,默林蛋白能够与魔奇蛋白和Grb2形成三元复合物。这些结果支持了默林蛋白在细胞表面受体介导的信号传导中的作用,并且可能对细胞骨架重组的调节具有重要意义。

相似文献

1
Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.神奇蛋白(Magicin)是一种新型细胞骨架蛋白,与神经纤维瘤病2型肿瘤抑制因子默林(merlin)和生长因子受体结合蛋白2(Grb2)相关联。
Oncogene. 2004 Nov 18;23(54):8815-25. doi: 10.1038/sj.onc.1208110.
2
DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin.DCC在人结肠癌来源的HT-29细胞中调节细胞黏附,并与埃兹蛋白相关联。
Eur J Cell Biol. 2006 Aug;85(8):769-83. doi: 10.1016/j.ejcb.2006.02.013. Epub 2006 Jun 8.
3
Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulation.Magicin与Src家族激酶结合,并在CD3刺激后发生磷酸化。
Biochem Biophys Res Commun. 2006 Sep 29;348(3):826-31. doi: 10.1016/j.bbrc.2006.07.126. Epub 2006 Jul 31.
4
Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells. Merlin 的抑瘤功能与其在施万细胞中作为肌动蛋白细胞骨架组织者的角色无关。
J Cell Sci. 2009 Nov 15;122(Pt 22):4141-9. doi: 10.1242/jcs.045914.
5
Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.神经纤维瘤病2型肿瘤抑制因子默林的定位及功能结构域
Cell Growth Differ. 1998 Apr;9(4):287-96.
6
Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.层粘连蛋白,一种细胞表面透明质酸受体,与默林和根蛋白相互作用。
Exp Cell Res. 2005 Aug 1;308(1):177-87. doi: 10.1016/j.yexcr.2005.04.017.
7
Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.默林/2型神经纤维瘤病通过抑制Ras和Rac的激活来抑制生长。
Cancer Res. 2007 Jan 15;67(2):520-7. doi: 10.1158/0008-5472.CAN-06-1608.
8
[Neurofibromatosis type 2 (NF2)].2型神经纤维瘤病(NF2)
Gan To Kagaku Ryoho. 1997 Sep;24(11):1427-31.
9
The tumour suppressor protein NF2/merlin: the puzzle continues.肿瘤抑制蛋白NF2/默林:谜题仍在继续。
J Clin Neurosci. 2001 Jan;8(1):4-7. doi: 10.1054/jocn.2000.0784.
10
Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.与埃兹蛋白/根蛋白/膜突蛋白相比,默林蛋白的表达水平、亚细胞分布及Rho-GDI结合亲和力。
Oncogene. 1999 Aug 26;18(34):4788-97. doi: 10.1038/sj.onc.1202871.

引用本文的文献

1
Skeletal muscle lncRNA profile associated with fatty acids in Nellore beef cattle.内洛尔肉牛中与脂肪酸相关的骨骼肌长链非编码RNA图谱
Sci Rep. 2025 Jul 18;15(1):26109. doi: 10.1038/s41598-025-11179-4.
2
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.2型神经纤维瘤病相关神经鞘瘤病的基因治疗:最新进展、挑战与未来方向
Oncol Ther. 2024 Jun;12(2):257-276. doi: 10.1007/s40487-024-00279-2. Epub 2024 May 17.
3
Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in -deficient models.
雷帕霉素复合物1选择性抑制剂RMC-6272(第三代双立体机制靶点)在β-缺陷模型中的临床前评估。
Neurooncol Adv. 2024 Feb 16;6(1):vdae024. doi: 10.1093/noajnl/vdae024. eCollection 2024 Jan-Dec.
4
Bioactive Vitamin D Attenuates MED28-Mediated Cell Growth and Epithelial-Mesenchymal Transition in Human Colorectal Cancer Cells.生物活性维生素 D 可减弱 MED28 介导的人结直肠癌细胞的生长和上皮间质转化。
Biomed Res Int. 2022 Aug 29;2022:2268818. doi: 10.1155/2022/2268818. eCollection 2022.
5
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.2型神经纤维瘤病雪旺细胞瘤小鼠模型中的基因替代疗法
Mol Ther Methods Clin Dev. 2022 Jun 22;26:169-180. doi: 10.1016/j.omtm.2022.06.012. eCollection 2022 Sep 8.
6
Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.神经纤维瘤病 2 型(NF2)与前庭神经鞘瘤和脑膜瘤发病机制的关系。
Int J Mol Sci. 2021 Jan 12;22(2):690. doi: 10.3390/ijms22020690.
7
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.mTOR 激酶抑制破坏了神经调节蛋白 1-表皮生长因子受体 3 自分泌信号,并使 NF2 缺陷型脑膜瘤细胞模型对 IGF1R 抑制敏感。
J Biol Chem. 2021 Jan-Jun;296:100157. doi: 10.1074/jbc.RA120.014960. Epub 2020 Dec 9.
8
Inactivation of mediator complex protein 22 in podocytes results in intracellular vacuole formation, podocyte loss and premature death.足细胞中介体复合物蛋白22的失活会导致细胞内液泡形成、足细胞丢失和过早死亡。
Sci Rep. 2020 Nov 18;10(1):20037. doi: 10.1038/s41598-020-76870-0.
9
Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.mTOR 激酶抑制剂联合 dasatinib 作为一种治疗前庭神经鞘瘤的新策略。
Sci Rep. 2020 Mar 6;10(1):4211. doi: 10.1038/s41598-020-60156-6.
10
The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.神经纤维瘤病 2 型肿瘤抑制因子 Merlin 与 Ras 和 RasGAP 相互作用,这可能调节 Ras 信号。
Oncogene. 2019 Sep;38(36):6370-6381. doi: 10.1038/s41388-019-0883-6. Epub 2019 Jul 16.